Sale!

Glyciphage SR 500mg Tablet

Original price was: 40.00₹.Current price is: 35.00₹.

Glyciphage is an anti-diabetic medication that belongs to the biguanide class of medicines. It is used in the treatment of type 2 diabetes mellitus and is an important part of diabetes management. The drug lowers glucose production in the liver and delays its absorption from the intestines.

- +

Generic Name

Metformin Hydrochloride (Sustained Release) – 500 mg


Brand Name

Glyciphage SR 500


Manufacturer

Franco-Indian Pharmaceuticals Pvt. Ltd.


Drug Class

Anti-diabetic (Biguanide group)


Uses / Indications

  • Helps control Type 2 Diabetes Mellitus

  • Reduces glucose production in the liver

  • Improves insulin sensitivity in body tissues

  • Helps in better utilization of glucose by muscles

  • May aid in weight management in diabetic patients

  • Lowers the risk of diabetes-related heart and vascular complications


Dosage & Administration

  • Usual dose: 1 tablet once or twice daily after meals

  • Sustained Release formulation ensures long-lasting effect

  • Dosage must be taken as prescribed by the doctor


Possible Side Effects

  • Nausea, vomiting

  • Diarrhea, abdominal discomfort, gas

  • Metallic taste in mouth

  • Long-term use may cause Vitamin B12 deficiency

  • Rare but serious: Lactic Acidosis (very uncommon but dangerous)


Precautions & Warnings

  • Use with caution in patients with kidney or liver disease

  • Avoid excessive alcohol consumption

  • Safe use during pregnancy or breastfeeding only under medical supervision

  • Inform your doctor if taking other anti-diabetic medicines or insulin


Drug Interactions

  • Alcohol → increases risk of lactic acidosis

  • Certain antibiotics (e.g., Ciprofloxacin)

  • Blood pressure medicines (ACE inhibitors, diuretics)


Storage

  • Store in a cool, dry place away from direct sunlight

  • Keep out of reach of children

Reviews

There are no reviews yet.

Be the first to review “Glyciphage SR 500mg Tablet”

Your email address will not be published. Required fields are marked *

Scroll to Top